On June 6, Gelonhui reported that up to June 6, 2024, Chimin Health Management (603222.SH) had repurchased 10,754,700 shares of the company's stock through centralized bidding trading, accounting for 2.002% of the company's total share capital of 537,237,415 shares. The highest purchase price was 9.98 yuan/share, and the lowest price was 5.00 yuan/share. The total amount paid for the repurchase was RMB 83,785,038 (excluding transaction costs).
济民医疗(603222.SH)：累计耗资8378.5万元回购2.002%股份
Chimin Health Management (603222.SH): Cumulative expenditure of 83.785 million yuan repurchasing 2.002% of its shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.